

Group 1 - The ChiNext Index opened high but experienced fluctuations and a decline on August 5, with the Tianhong ChiNext ETF (159977) down by 0.33% [1] - Among the constituent stocks, Watson Bio rose over 4%, with other stocks like Jingjia Micro, Guanghong Technology, Huace Navigation, and Lens Technology also seeing gains [1] - As of August 5, the Tianhong ChiNext ETF (159977) had a circulating scale exceeding 8.3 billion yuan, ranking among the top three in similar products [1] Group 2 - According to the Economic Reference Daily, brokerages have released optimistic strategies for August, viewing the market's recent pullback as a temporary adjustment influenced by policy support, improved corporate earnings, and new capital inflows [2] - Huatai Securities noted that the current market's profit effect has returned to mid-July levels, suggesting that the A-share market may enter a period of increased volatility with active local hotspots [2] - Everbright Securities highlighted that the recent positive news in innovative drugs has led to a surge in pharmaceutical stocks, driving the ChiNext Index higher, and expects a continuation of a structural market trend [2]